Autopsy report · NCT05877404

Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer

“This was a national survey of physicians. Per the protocol, they were only allowed to be contacted twice and they received less surveys back than anticipated.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 6 months before it stopped.
• 112 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Wake Forest University Health Sciences

Sponsor type

University, hospital or other

Conditions

Endometrial Cancer

Interventions

Surveys

Participants

112

Sites

1

Countries

United States

Trials that died the same way

• Implementation of Digital Vital Sign Monitoring to Decrease Sleep Interruption and Enhance Recovery in Phase II of the PROmoting Sleep, Patient Engagement and Recovery (PROSPER) Project
  “Poor accrual and poor patient engagement with survey completion” (60% match in meaning)
• Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients
  “small number of patients got recruited” (56% match in meaning)
• Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer
  “The number of patients enrolled was much less than expected” (56% match in meaning)
• Saracatinib in Treating Patients With Prostate Cancer
  “Per protocol, study was terminated due to low rate of randomized patients.” (55% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.